Skip to content
HeyJared

Biotech Currents

Clinical & Regulatory Catalysts Driving BioPharma & MedTech Stocks Started by SanaCurrents ("SC"), a service established to identify which stocks, valued entirely on the promise of developing a new, novel drug, has the best chance for value appreciation.

Newsletter · By Bill Langbein · Official site

Indexed issues, last 90 days
1
Latest publication
Aug 12, 2026
Audience
Checking…
Earliest in this view
Aug 12, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest issues

  1. Issue · Aug 12, 2026

    Biomatrix Device Drives Two Product Sales, With Breast Reconstruction Next (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="402" src="https://substackcdn.com/image/fetch/$s_!3U3t!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7d9b9058-a1b2-4ece-ad8c-6f8d4a8c1439_1254x1254.pn

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Biotech Currents